Immune System and Cancer
Add to My Pictures
|Title:||Immune System and Cancer|
Cancer immunotherapy has emerged as a powerful tool in cancer treatment. The key insight was that a patient’s own immune system could be harnessed to recognize and destroy cancer cells. Allen joined a phase 1 trial at the NIH Clinical Center, one of several sites testing a combination of rituximab (Rituxan) with Hu5F9-G4, a monoclonal antibody that blocks the CD47 protein on tumor cells. This treatment exposes tumor cells to destruction by the immune system.
This image is part of the NCI Annual Plan and Budget Proposal FY 2021 collection.
See also www.cancer.gov/about-nci/budget/plan.
|Type:||Color, Illustration (JPEG format)|
|Source:||National Cancer Institute (NCI)|
|Date Created:||September 3, 2019|
|Date Added:||September 3, 2019|
|Reuse Restrictions:||None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.|